West Chester, OH, United States of America

Frederick Ryckman

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Manistee Partners LLC, Cincinnati Children's Hospital Medical Center. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick Ryckman. Retrieved from https://idiyas.com/inventor/frederick-ryckman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Frederick Ryckman

Introduction

Frederick Ryckman is a notable inventor based in West Chester, Ohio, recognized for his significant contributions to the field of migraine treatment. With a total of three patents to his name, Ryckman's work focuses on innovative methods and compositions aimed at alleviating the suffering caused by migraines.

Latest Patents

Ryckman's latest patents include groundbreaking compositions for the treatment of migraines. One patent details prostaglandin Fanalog compositions and methods specifically designed for migraine relief. Another patent elaborates on prostaglandin F2alpha analog compositions and methods for treating migraines through topical administration. This method involves applying a composition containing a prostaglandin F2alpha analog or its pharmaceutically acceptable salt to a subject in need. The treatment can be administered either prophylactically or therapeutically, targeting areas such as the epidermis, conjunctival surface, or other mucous membranes. The prostaglandin F2alpha analogs mentioned include latanoprost, isopropyl unoprostone, bimatoprost, travoprost, and tafluprost.

Career Highlights

Throughout his career, Ryckman has worked with various organizations, including Manistee Partners LLC and Cincinnati Children's Hospital Medical Center. His experience in these institutions has contributed to his expertise in developing effective treatments for migraines.

Collaborations

Ryckman has collaborated with notable individuals in his field, including Robert L. Bratzler and Martin Wand. These partnerships have likely enhanced his research and development efforts, leading to innovative solutions for migraine sufferers.

Conclusion

Frederick Ryckman's contributions to migraine treatment through his patents and collaborations highlight his dedication to improving the quality of life for those affected by this condition. His innovative approaches continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…